Urgo US, Inc.

11 patents currently held · Updated Nov 15, 2026

3 more in force are now held by other companies

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Previously recorded as Realm Therapeutics, Inc. (to 2020)

Ending by 2030

Jan 2028

Next term end

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.

1 fee due Sep 3, 2027
The maintenance fee for Stabilized hypohalous acid solutions (US 10,576,152) comes due Sep 3, 2027. Unpaid by Mar 3, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Patent	Title	Status	Expires	Confidence
US 9,999,635	Methods and compositions for treating inflammatory disorders In force Term ends Jan 16, 2028 · From the USPTO record	In force	Term ends Jan 16, 2028	From the USPTO record
US 10,617,716	Hypochlorous acid formulations and methods for treating skin conditions In force Term ends Jan 16, 2028 · From the USPTO record	In force	Term ends Jan 16, 2028	From the USPTO record
US 8,877,257	Methods and Compositions for Treating Conditions Associated with Infection And/Or Inflammation In force Term ends Mar 11, 2031 · High confidence	In force	Term ends Mar 11, 2031	High confidence
US 9,381,214	Methods for treating skin irritation In force Ends no later than Mar 19, 2032 · From the USPTO record	In force	Ends no later than Mar 19, 2032	From the USPTO record
US 9,392,787	Stabilized hypohalous acid solutions In force Ends no later than Mar 19, 2032 · From the USPTO record	In force	Ends no later than Mar 19, 2032	From the USPTO record
US 9,414,584	Stabilized Hypohalous Acid Solutions In force Term ends Mar 19, 2032 · High confidence	In force	Term ends Mar 19, 2032	High confidence
US 9,925,217	Methods for treating inflammation associated with allergic reaction In force Ends no later than Mar 19, 2032 · From the USPTO record	In force	Ends no later than Mar 19, 2032	From the USPTO record
US 10,034,942	Stabilized hypohalous acid solutions In force Ends no later than Mar 19, 2032 · From the USPTO record	In force	Ends no later than Mar 19, 2032	From the USPTO record
US 10,576,152	Stabilized hypohalous acid solutions In force Ends no later than Mar 19, 2032 · From the USPTO record	In force	Ends no later than Mar 19, 2032	From the USPTO record
US 11,452,778	Stabilized hypohalous acid solutions In force Term ends Mar 19, 2032 · From the USPTO record	In force	Term ends Mar 19, 2032	From the USPTO record

10 of 11 patents shown.

Pro members see all 11.

Pro members: see all 11 patents

Also on record, not counted in the 11: 3 patents in force now held by others · 3 lapsed for an unpaid fee · 2 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro

Published applications

Every application published under this name has become a patent.